These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28426665)

  • 1. Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.
    Peterson TA; Gauran IIM; Park J; Park D; Kann MG
    PLoS Comput Biol; 2017 Apr; 13(4):e1005428. PubMed ID: 28426665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain landscapes of somatic mutations in cancer.
    Peterson TA; Park D; Kann MG
    AMIA Jt Summits Transl Sci Proc; 2013; 2013():136. PubMed ID: 24303323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain landscapes of somatic mutations in cancer.
    Nehrt NL; Peterson TA; Park D; Kann MG
    BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
    Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
    Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein domain-level landscape of cancer-type-specific somatic mutations.
    Yang F; Petsalaki E; Rolland T; Hill DE; Vidal M; Roth FP
    PLoS Comput Biol; 2015 Mar; 11(3):e1004147. PubMed ID: 25794154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
    Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
    Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants.
    Grillo E; Ravelli C; Corsini M; Zammataro L; Mitola S
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188614. PubMed ID: 34403770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census.
    Malhotra S; Alsulami AF; Heiyun Y; Ochoa BM; Jubb H; Forbes S; Blundell TL
    PLoS One; 2019; 14(7):e0219935. PubMed ID: 31323058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutational landscape of phosphorylation signaling in cancer.
    Reimand J; Wagih O; Bader GD
    Sci Rep; 2013 Oct; 3():2651. PubMed ID: 24089029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protein domain-centric approach for the comparative analysis of human and yeast phenotypically relevant mutations.
    Peterson TA; Park D; Kann MG
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S5. PubMed ID: 23819456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating molecular and functional context into the analysis and prioritization of human variants associated with cancer.
    Peterson TA; Nehrt NL; Park D; Kann MG
    J Am Med Inform Assoc; 2012; 19(2):275-83. PubMed ID: 22319177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of somatic mutations in tumors using unaligned clonal sequencing data.
    Sutton KM; Crinnion LA; Wallace D; Harrison S; Roberts P; Watson CM; Markham AF; Bonthron DT; Quirke P; Carr IM
    Lab Invest; 2014 Oct; 94(10):1173-83. PubMed ID: 25068661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating somatic tumor mutation detection without matched normal samples.
    Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
    Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-structure-guided discovery of functional mutations across 19 cancer types.
    Niu B; Scott AD; Sengupta S; Bailey MH; Batra P; Ning J; Wyczalkowski MA; Liang WW; Zhang Q; McLellan MD; Sun SQ; Tripathi P; Lou C; Ye K; Mashl RJ; Wallis J; Wendl MC; Chen F; Ding L
    Nat Genet; 2016 Aug; 48(8):827-37. PubMed ID: 27294619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational approaches to identify functional genetic variants in cancer genomes.
    Gonzalez-Perez A; Mustonen V; Reva B; Ritchie GR; Creixell P; Karchin R; Vazquez M; Fink JL; Kassahn KS; Pearson JV; Bader GD; Boutros PC; Muthuswamy L; Ouellette BF; Reimand J; Linding R; Shibata T; Valencia A; Butler A; Dronov S; Flicek P; Shannon NB; Carter H; Ding L; Sander C; Stuart JM; Stein LD; Lopez-Bigas N;
    Nat Methods; 2013 Aug; 10(8):723-9. PubMed ID: 23900255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
    Sun S; Thorson JA; Murray SS
    Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computational and structural analysis of germline and somatic variants affecting the DDR mechanism, and their impact on human diseases.
    Magraner-Pardo L; Laskowski RA; Pons T; Thornton JM
    Sci Rep; 2021 Jul; 11(1):14268. PubMed ID: 34253785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
    Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
    BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.